The first case of COVID-19 treated with the complement C3 inhibitor AMY-101
Sara Mastaglio, Annalisa Ruggeri, Antonio M. Risitano, Piera Angelillo, Despina Yancopoulou, Dimitrios C. Mastellos, Markus Huber‐Lang, Simona Piemontese, Andrea Assanelli, Cecília Garlanda, John D. Lambris, Fabio Ciceri
Topics & Concepts
ARDSCytokine stormPneumoniaMedicineImmunologyComplement systemImmune systemCoronavirus disease 2019 (COVID-19)Innate immune systemCytokine release syndromeLungT cellInternal medicineInfectious disease (medical specialty)Chimeric antigen receptorDiseaseCOVID-19 Clinical Research StudiesComplement system in diseasesCOVID-19 Impact on Reproduction